A Cohort Study on the Safety and Efficacy of XH-02 in Treating Hypoparathyroidism

NCT07540286 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Hypoparathyroidism

Interventions

DRUG: Single subcutaneous injection
DRUG: Multiple subcutaneous injection

Sponsor

Peking Union Medical College Hospital